How do you manage favorable intermediate risk prostate cancer patients that have a PIRADS 5 lesion that was most-likely missed in the template biopsy?  

For example, a patient that received an MRI after biopsy that demonstrates a PIRADS 5 lesion in anterior TZ which likely was not sampled on biopsy. Would you request directed biopsy of the PIRADS 5 lesion prior to commencing RT+/-ADT?



Answer from: at Community Practice

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Lafayette Radiation Center
2 ways to approach this common issue. Repeat th...
Sign in or Register to read more